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Abstract: This paper uses multivariate methods on actual data from 267 patients with non-
insulin-dependent (Type 2) diabetes mellitus in order to see how the various risk factors can 
affect the progression of diabetic nephropathy. The approach succeeds in identifying 
preliminary risk factors such as smoking for males, although the females had higher fasting 
blood glucose at diagnosis. Not surprisingly, hypertension is common among patients of both 
sexes and it has an association with proteinuria in female patients in the sample. 
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Introduction 
In a previous paper [8], we used univariate analysis to look for risk factors for diabetic 
nephropathy. However, examination of each independent variable individually can only 
provide a preliminary idea of how important each variable is by itself. The relative importance 
of all the variables has to be examined simultaneously by multivariate methods. In this paper 
linear logistic regression analysis is adopted in attempt to identify the risk factors related to 
diabetic kidney disease.  
 
The rationale for using linear logistic regression for analysis is that it is not required to 
assume the normal distribution for the independent variables. Now in our case, many of the 
independent variables are qualitative or measured in nominal or ordinal scales and often in 
such cases any such normality assumption is violated.  
 
Thus, once we have an overview of the data by from univariate analysis, we can further our 
investigation by using multivariate analysis. The rationale for using the multivariate method is 
that the univariate approach may ignore the possibility that a collection of variables, each of 
which is weakly associated with the outcome, can become an important predictor of the 
outcome when taken together. 
 
Proteinuria 
Research suggests that measurement of proteinuria is the most accurate way for the screening 
and diagnosis of overt diabetic nephropathy. Moreover, protein measurement in spot urine is a 
reliable and simple method for the screening and diagnosis of overt diabetic nephropathy [11]. 
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Persistent proteinuria is defined as a protein excretion > 0.5 g/24 h in at least four consecutive 
urine samples with an interval of at least 1 month in patients without renal infection. 
Persistent proteinuria is strongly associated with increased mortality in insulin-dependent 
diabetes mellitus (IDDM), and risk of this condition can be predicted many years in advance 
by subclinical increases in albumin excretion rate (microalbuminuria) [2]. It was found that 
the reduction in albumin excretion rate was accompanied by a significant fall in median 
glomerular filtration rate (GFR) and a fractional renal clearance of albumin. Kidney volume 
remained unchanged.  
 
Microalbuminuria, the early phase of diabetic nephropathy, is associated with increased 
cardiovascular morbidity and mortality, but the reason for this is not clear [3]. Patrick et al. [6] 
assessed the prevalence of microalbuminuria, and its associations with other clinical features. 
The study showed that persistent microalbuminuria was found in a significant number of non-
insulin-dependent diabetes (NIDDM) patients at the time of diagnosis.  
 
Similarly, the impact of microalbuminuria on mortality among a large cohort of NIDDM and 
other risk factors was investigated by Schmitz et al. [7]. They found that age, urine albumin 
concentration (UAC), known duration, and serum creatinine were the only significant risk 
factors. More specifically, Turtle [9] explained that patients with microalbuminuria have an 
increased risk of developing diabetic nephropathy, hypertension, large vessel disease and 
retinopathy. Hence epidemiological studies have focused on the identification of risk factors 
for the development of microalbuminuria. In the same way, the United Kingdom Prospective 
Diabetes Study Group [10] concluded that urinary albumin excretion was associated with 
hyperglycaemia and hypertension, whereas urinary N-acetyglycaeminidase was primary 
associated with hyperglycaemia. 
 
Data 
The longitudinal data of the diabetic patients have been collected by Professor David Owens 
CBE and his team at the Diabetes Research Unit, University of Cardiff School of Medicine, 
with which the authors have worked over the years. The data set consists of measurements of 
age, sex, weight, height, blood glucose, cholesterol, high and low density lipoprotein, blood 
pressure, urea and creatinine, together with various demographic and biochemical data for 
267 NIDDM patients (75 females, 192 males).  
 
However, it is more informative to compare the means of different variables of the patients' 
characteristics classified by sex. The results are tabulated in Table 2. 
 
Logistic regression analysis 
Logistic regression is used for situations in which one wants to be able to predict the presence 
or absence of characteristics or outcomes based on values of a set of predictor variables. It is 
similar to a multiple linear regression model but is suited to models where the dependent 
variable is dichotomous. Thus the method is usually applied to the case when one considers 
the binary variable which gives the categories numerical values of 0 and 1, usually 
representing `No' and `Yes' respectively, so that the mean of these values in a sample of 
individuals is the same as the proportion of individuals with the characteristic. 
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  Table 1. Summarized statistics of all the metric variables 
 
Variable N  Minimum Maximum  Mean  Std.  deviation 
Age [year]  267  17  78  52.73  10.97 
BMI [kg/m
2] 267  17.15  48.73  28.66  5.08 
Cholesterol [mmol/l]  248  2.8  11.4  5.33  1.24 
Creatinine [µmol/l]  257 44.00  176  86.00  17.25 
Dia_BP [mm Hg]  262  58  120  85.08  10.00 
HBA1c [%]  265  6.7  19.3  11.2  2.4 
HDL [mmol/l]  243  0.4  2.2  1.08  0.32 
Height [m]  267  1.49  1.95  1.69  0.09 
LDL [mmol/l]  239  0.7  7.5  3.25  1.06 
MTT [mmol/l]  267  5.6  20.5  11.75  3.37 
OGTT [mol/l]  267  5.8  22.8  12.0  3.5 
Sys_BP [mmHg]  262  92  210  138.8  20.4 
Triglyceride [mmol/l]  248  0.4  10.7  2.1  1.3 
Urea [mmol/l]  261  2.2  11.5  5.4  1.3 
Weight [kg]  267  45  135.5  81.5  14.7 
Valid N [listwise]  232         
 
  Table 2. Means of patient characteristics 
 
Female Male 
Variable 
Mean SD N  Mean SD  N 
p Value 
Age 50.38  11.25  75  53.64  10.29  192      0.029 
BMI 31.10 6.13  75  27.71  4.27  192  <  0.000 
Cholesterol 5.56 1.30  71 5.23  1.35  177  0.059 
Creatinine 73.02 12.48  71 90.95  16.65 186  <  0.000 
Dia_BP 83.22 10.43  73 85.79  9.41 189 0.0620 
HBA1c 11.69 2.42  73  11.06  2.27  192  0.056 
HDL 1.15 0.34  71 1.04  0.32  172  0.016 
Height 1.59 0.066 75 1.72  0.079 192  <  0.000 
LDL 3.45 1.03  71 3.15  1.07  168  0.048 
MTT 12.42 3.35  75  11.49  3.36  192  0.042 
OGTT 12.70 3.408 75  11.68  3.466 192  0.033 
Sys_BP 139.30 22.31  73  138.58  19.46 189 0.800 
Triglyceride 1.97 1.18  71 2.18  1.19  177  0.278 
Urea 5.08 1.53  72 5.57  1.26  189  0.010 
Weight 79.53 16.69  75 82.30  14.09 192 0.169 
 
Now suppose that there are n diabetic patients for some of whom the health-related event (for 
instance, presence of proteinuria) has occurred. They are called successes, while the others are 
failures. Let  1 i y =  if the 
th i  individual is a success and  0 i y =  if the 
th i  individual is a failure. 
Suppose that for each of the n individuals,  p  independent variables  1,....., ii p x x  are measured. 
These variables can be qualitative, such as sex and race, or quantitative, such as blood 
pressure and body mass index. The problem now is to relate the independent variables 
1,....., ii p x x  to the dichotomous dependent variable  i y .  BIO
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One obvious method often suggested is the ordinary multiple linear regression technique. 
Assume that the  ' j ys   are normally distributed with mean  i P  and  variance 
2 σ , and  i P , 
defined as the probability of success, or 
 
1
1
( 1 | ,...., )
1 ( 0 | ,...., )           1,...,
ii i i p
ii i i p
PP y x x
PP y x x i n
==
-= = =
 (1) 
is linearly dependent on  ' ij x s  The model may be written as 
1
p
ij i j
j
Pb x
=
=∑  (2) 
Then a least-squares technique is applied to estimate the coefficients  j b . Consequently, for a 
new individual patient,  i P   can be estimated by substituting its  ij x   values into Eq. (2). 
However, using this method and treating the dichotomous dependent variable as if it is 
quantitative, has at least two limitations. Firstly, the ' j ys  are not normally distributed and 
hence the ordinary linear regression may not be validly applied in this situation. Secondly, it 
may also be possible that the least-square estimate for  i P  obtained from Eq. (2) may have the 
result that the fitted value does not satisfy the condition 0 1. i P ≤ ≤  Due to these limitations a 
more appropriate model, known as the logistic regression model, will be used to solve this 
kind of problem where the dependent variable is dichotomous. 
 
The logistic regression model 
The basic principle of logistic regression is much the same as for ordinary multiple regression. 
The main difference is that instead of developing a model that uses a linear combination of 
the values of a group of predictor variables to predict the value of a dependent variable, the 
group of predictor variables is used to predict a transformation of the dependent variable. 
 
Thus in the linear logistic model, the dependence of the probability of success on the 
independent predictor variables is assumed to be 
1
1
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 (4) 
Hence the logarithm of the ratio of  i P  and 1 , i P −  known as the logit transformation, is given 
by BIO
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and is a simple linear function of the  . ij x s  
 
Eq. (5) is also called the log odds. The logistic regression coefficients  ' j bs  can be used to 
estimate odds ratio for each of the independent variables in the model. Thus from our model, 
if we wish to compare predictions for subjects with or without a particular characteristic, such 
as systolic blood pressure greater than 140 mm Hg, we will estimate  () 11  logit lp =  for one 
group of subjects and  () 22  logit lp =  for the other. Then we have 
() () ( )
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12 12
12 1 2
12 2 1
1
logit logit log log log
11 1
p p pp
ll p p
p pp p
⎛⎞ − ⎛⎞ ⎛⎞
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 (6) 
which is the logarithm of the odds ratio. 
 
From the estimated regression Eq. (3) a predicted probability of success can be computed by 
substituting the values of the risk factors in the equation. Using these predicted probabilities, a 
goodness-of-fit test can be performed to test the hypothesis that the model fits the data 
adequately. Several such tests are applicable, such as the Pearson chi-square test, and the 
Hosmer-Lemeshow test, we are going to utilise them in testing the goodness-of-fit of the full 
model. 
 
Results from the analysis of the diabetic patients' data 
In this section we are going to utilize logistic regression to analyse the diabetic patients' data. 
The goal of the analysis is to investigate, by using logistic regression, which of the factors are 
predictive of proteinuria. In our data set we have 267 patients with some measure of their 
personal characteristics, such as age, sex, weight, height, and their fasting blood glucose, 
measured by oral glucose tolerance test (OGTT), or meal tolerance test (MTT), and the 
glycoslated hemoglobin (HbA1c). Measurements are also made on their lipids level, such as 
cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), and triglyceride 
(TG). Moreover, their renal functions; such as urea and creatinine levels are recorded. Apart 
from these, their systolic and diastolic blood pressure, body mass index (BMI) and their 
smoking habit are also noted.  
 
Full model 
Extensive data analysis, using the logistic regression technique, reveals that among 
267 patients, only 128 patients have records of presence/absence of proteinuria, hence these 
128 patients' data will be utilized in the logistic regression. The logistic regression method is 
used to identify the most important risk factors and to predict the probability of proteinuria on 
the basis of these risk factors. By using MINITAB, the final result is tabulated in Fig. 1. 
 
From Fig. 1 the procedure identifies that the most important risk factors for proteinuria (hence 
diabetic nephropathy) are mainly from lipid levels, namely, cholesterol, high density 
lipoprotein (HDL), low density lipoprotein (LDL), and triglyceride (TG). Moreover, the other 
two risk factors identified are retinopathy and body mass index (BMI). 
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Binary Logistic Regression
NOTE: BEST FULL MODEL for the diabetic patients
Link Function:  Logit
Response Information
Variable  Value       Count
PROT      1              28  (Event)
          0             100
          Total         128
  128 cases were used
  139 cases contained missing values
Logistic Regression Table
                                                   Odds        95% CI
Predictor       Coef      StDev        Z     P    Ratio    Lower    Upper
Constant      -4.810      1.965    -2.45 0.014
CHOL          1.4114     0.5860     2.41 0.016     4.10     1.30    12.93
HDL          -2.2020     0.9234    -2.38 0.017     0.11     0.02     0.68
LDL          -0.9621     0.5411    -1.78 0.075     0.38     0.13     1.10
TG           -1.3776     0.4527    -3.04 0.002     0.25     0.10     0.61
RET(2)        1.7119     0.7024     2.44 0.015     5.54     1.40    21.95
BWI          0.13619    0.04786     2.85 0.004     1.15     1.04     1.26
Log-Likelihood = -57.311
Test that all slopes are zero: G = 19.860, DF = 6, P-Value = 0.003
Goodness-of-Fit Tests
Method                Chi-Square    DF      P
Pearson                  117.137   121  0.582
Deviance                 114.622   121  0.646
Hosmer-Lemeshow           11.037     8  0.200
 
Fig. 1 Estimated coefficients for a linear regression model 
using data from diabetic patients 
 
Validation of the model 
In order to test the goodness of fit of the model, we refer to Fig. 1 which provides us with 
details of the test. In the first place we observed that when testing the null hypothesis that all 
slopes are zero, the G value is 19.860, with a p value of 0.03, hence we can conclude that at 
least one of the slope (that is, the risk factor) is significantly different from zero. Also from 
the Hosmer-Lemeshow test, the p value is 0.2, indicating that the data fits the model. Actually 
from the MINITAB output we observe that practically all the other two methods, namely the 
Pearson test and the Deviance test show that the model is a good-fit (that is, with all their p 
values greater than 0.05). 
 
Now we can further investigate whether the data set contains any outlier. The best way to 
investigate this is by referring to the analysis of residuals. The delta deviance vs. probability 
plot is shown in Fig. 2. The plot is used to identify factor/covariate patterns that have not been 
fit well by the model. The delta deviance measures the change in the deviance goodness-of-fit 
statistic due to deleting a particular factor/covariate pattern. Now from the Fig. 2 we observe 
that all the data are distributed evenly and there are no particular outliers being noted. Hence 
we can conclude that there is no outlier being identified with the set of data. 
 
Bias due to missing data 
In order to investigate the bias due to missing data, it is better to divide the data set into two 
portions. One is for those data which are included in the model, and the other is not included. 
Then we can compare the mean of different characteristics of the two set of data, at baseline, 
and investigate the difference between them. BIO
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Fig. 2 Delta deviance versus probability 
 
  Table 3. Table of means of patients’ characteristics classified  
  by included/not included in model 
 
Included in model  Not included  Variable 
Mean SD  N  Mean  SD  N 
p Value 
Age 52.5  11.4  128 52.9  10.6  139  0.76 
BMI 29.04  5.12  128 28.32  5.04 139  0.25 
Cholesterol 5.05  1.00 128 5.62  1.40  120  0.00 
Creatinine 88.2  16.7  126 83.9  16.65 186  0.043 
Dia_BP 87.44  9.6  124 82.96  9.92 138  0.00 
HBA1c   87.44  9.6  124  82.96  9.92  138  0.00 
HDL 1.135  0.342 128  1.01  0.298 115 0.028 
Height 1.694  0.091 128  1.68  0.095 139 0.561 
LDL 3.027  0.95  128  3.5  1.13  111 0.11 
MTT 11.52  3.37  128 11.97  3.38 139  0.28 
OGTT 11.7  3.49  128 12.21  3.59 139  0.237 
Sys_BP 144.3  20.3  124 113.9  19.2  138  0.00 
Triglyceride 1.96  1.24 128 2.29  1.47  120  0.061 
Urea 5.35  1.41 128 5.53  1.34  133  0.289 
Weight 83.1  14.8  128 80.1  14.6  139  0.1 
 
Also for those characteristics presented as categorical data, we can use the chi-square test to 
find whether there is any association between those included in model and those not included, 
and the result is given in Table 4. 
 
Now we discuss the results of Table 3 and Table 4 in terms of  0.01, p <  due to the fact that 
there are so many variables under consideration. From Table 3 we observe that for the 
majority of the characteristics their mean values have no significant difference between the 
two groups, except only for cholesterol, diastolic BP, systolic BP, HBA1c. Now the model we 
obtained consisted of the variables of BMI, cholesterol, HDL, LDL, TG, RET(2), and BMI, 
out of which only cholesterol shows a significant difference between the two groups of 
patients (that is, included/not included). As a matter of fact the mean value for cholesterol for BIO
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those not included is 10% higher than those included in the model. So this may be the only 
risk factor which needs further investigation as reflected from the data. While for all the other 
factors, the mean values show no significant difference between two groups. From Table 4 we 
also observe that for retinopathy, there is no significance between two groups, hence we can 
say that we are justified in using the model for diagnostic purposes for patients who are most 
likely to develop proteinuria with later onset of nephropathy. 
 
  Table 4. Table of chi-square test p values for categorical 
  data classified by included/not included in model 
 
Variables Chi-square  test  p values 
Sex 0.795 
Smoke 0.001 
Ret 0.411 
Prot 0.076 
 
However, it must be borne in mind that there may be some bias due to the missing data as we 
have seen that nearly half of the data have missing values, but as we have mentioned before, 
missing data are a common phenomena in collecting clinical data, and unfortunately we 
cannot do anything about it at the present stage. 
 
Interpretation of results 
In this chapter we have performed two kinds of data analysis. The first and preliminary one is 
the univariate analysis. Univariate analysis based on t-test or classification of the variables in 
contingency table in order to test the association of different variables with the status of 
presence/absence of proteinuria should provide us the information on which variables should 
be included into the experimental model. 
 
From our results we observed that if the whole group of patients is taken into consideration, 
the only obvious risk factor for nephropathy so obtained is age. This is in accord with the 
literature (Lee et al., [4]). However, we know from Table 2 that there is a marked difference 
between the male and female characteristics from the patients' statistics classified by sex. 
Hence we suspect that sex may be a confounding factor. So it is beneficial to classify the 
patients' data by sex and perform further investigation. In doing so we discovered that if we 
classified the age into four categories and using chi-square test, the association between age 
and proteinuria is significant among male patients, while such association among female 
patients is considered to be non-significant. Hence this reinforces our conviction that sex may 
be a confounding factor. 
 
Another possible risk factor of interest is BMI, for obesity should be associated with diabetes 
and nephropathy. However, such a hypothesis is not supported by the univariate data analysis. 
Even when the data are subdivided by sex, the results are still not significant. In fact, the only 
significant association observed is between retinopathy and BMI (Fig. 3). 
 
Hypertension is another possible risk factor often mentioned in the literature. However, in our 
data analysis, only hypertension in terms of diastolic BP among female patients was found to 
have strong association with proteinuria. For hypertension in terms of systolic blood pressure, 
no such association with proteinuria is obtained. 
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Fat * RETINOPATHY * SEX Crosstabulation
12 1 2 1 16
75.0% 6.3% 12.5% 6.3% 100.0%
49 4 3 3 59
83.1% 6.8% 5.1% 5.1% 100.0%
61 5 5 4 75
81.3% 6.7% 6.7% 5.3% 100.0%
58 5 16 6 85
68.2% 5.9% 18.8% 7.1% 100.0%
92 3 7 5 107
86.0% 2.8% 6.5% 4.7% 100.0%
150 8 23 11 192
78.1% 4.2% 12.0% 5.7% 100.0%
Count
% within Fat
Count
% within Fat
Count
% within Fat
Count
% within Fat
Count
% within Fat
Count
% within Fat
normal
fat >26.5
Fat
Total
normal
fat >26.5
Fat
Total
SEX
Female
Male
absence presence moderate serious
RETINOPATHY
Total
Chi-Square Tests
1.176a 3 .759
75
9.422b 3 .024
192
Pearson Chi-Square
N of Valid Cases
Pearson Chi-Square
N of Valid Cases
SEX
Female
Male
Value df
Asymp.
Sig.
(2-sided)
6 cells (75.0%) have expected count less than 5. The minimum
expected count is .85.
a. 
3 cells (37.5%) have expected count less than 5. The minimum
expected count is 3.54.
b. 
 
Fig. 3 Two way table of BMI group and retinopathy group for diabetic patients 
classified by sex 
 
When we subdivide the patients further according to smoking habit, we observe that the 
triglyceride level shows a significant difference between different proteinuria status (i.e. 
absence/presence of proteinuria). Hence lipid level does become a risk factor for nephropathy 
among some particular patients with certain characteristics. Table 5 shows that nearly all the 
significance difference between the patients with status of proteinuria are male. Hence we can 
conclude that male patients may be at higher risk of developing proteinuria or nephropathy 
than female patients. 
 
  Table 5. Summary statistics for variables from patients with 
 different  characteristics by proteinuria status 
 
Proteinuria Status 
No Yes  Patient characteristics  Variable 
Mean SD Mean  SD 
p value 
Male Age  56.13  10.35  50.00  8.84  0.003 
Male  Triglyceride  2.08 1.32 1.648  0.567 0.027 
Smoker  Triglyceride  2.54 1.72 1.77 0.51 0.031 
Male non-smoker  Age  56.40  11.18  51.19  8.06  0.046 
Male  non-smoker  MTT  11.59 3.55 9.71 2.39 0.019 
Male smoker  Age  55.61  8.65  48.54  9.84  0.038 
Male  smoker  Triglyceride  2.48 1.84 1.70 0.45 0.055 
Male hypertension (SBP)  Age  57.37  10.60  52.55  8.91  0.059 
Male hypertension (DBP)  LDL  3.11  0.87  2.37  1.26  0.047 
 
 
Now the result of the multivariate logistic regression shows that the risk factors for 
nephropathy are mainly associated with lipid levels, namely, cholesterol, high density 
lipoprotein (HDL), low density lipoprotein (LDL), and triglyceride (TG). When compared BIO
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with the univariate analysis, only triglyceride is classified as risk factor among male smokers. 
Thus multivariate analysis enables us to include more variables under consideration. The 
significant association between lipid levels and nephropathy is supported by Boemi et al. [1] 
who conducted a study to examine the hypothesis that kidney function is an independent 
determinant of lipoprotein (a) [Lp(a)] concentrations in people with diabetes. They discovered 
that for both type 1 and type 2 patients, renal disease (i.e., macroalbuminuria) is a determinant 
of increased Lp(a) concentration. Thus it is not surprised to see that there is a strong 
association of proteinuria with lipids level in our data analysis. 
 
The other two risk factors identified by logistic regression are BMI and retinopathy. Both 
were not revealed in the univariate analysis. As mentioned previously they may be only 
weakly associated with proteinuria and hence they were overlooked when univariate analysis 
was performed. Relatively high BMI can be associated with low physical exercise, obesity, 
and stress, which increase insulin demand [5]. 
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